Apso dogs has been established and the molecular basis of hemophilia B has been determined. The plasma factor IX levels were <1% of normal canine levels in affected dogs. A complex deletion mutation at nucleotides 772-777 was found when hepatocyte cDNA from a hemophilia B dog was sequenced. The sequence was identical to the normal canine sequence except for a deletion including nucleotides 772-776 and a C -. T transition at nucleotide 777. The mutation results in mRNA instability and a premature termination co-EMOPHILIA B is a X-linked, recessive bleeding disor-H der caused by a deficiency of blood coagulation factor IX (FIX). It occurs in approximately 1 out of every 30,000 males and accounts for approximately 15% of the hemophilic disorders.'.' Factor IX is a 56-kD plasma glycoprotein in the intrinsic clotting cascade that is synthesized by hepatocytes. Factor IX is initially produced as an inactive protease (FIX), which is then modified to its active form as a serine protease (FIXa) by proteolytic removal of the activation peptide by factors XIa or VIIa-tissue factor. Factor IXa in the presence of its cofactor VIIIa, calcium and phospholipids activates factor X.
H der caused by a deficiency of blood coagulation factor IX (FIX). It occurs in approximately 1 out of every 30,000 males and accounts for approximately 15% of the hemophilic disorders.'.' Factor IX is a 56-kD plasma glycoprotein in the intrinsic clotting cascade that is synthesized by hepatocytes. Factor IX is initially produced as an inactive protease (FIX), which is then modified to its active form as a serine protease (FIXa) by proteolytic removal of the activation peptide by factors XIa or VIIa-tissue factor. Factor IXa in the presence of its cofactor VIIIa, calcium and phospholipids activates factor X.
The nucleotide sequence for the human FIX gene has been r e p~r t e d .~
The gene consists of approximately 33.5 kb of DNA, including seven introns (a to g) and eight exons (1 to 8). Each exon codes for a unique domain within the FIX protein. Exon 1 encodes the signal peptide, exons 2 and 3 encode the propeptide and gamma carboxyglutamyl domains, exon 4 encodes the first epidermal growth factor (EGF)-like domain, exon 5 encodes the second EGF domain, exon 6 encodes the activation peptide, and exons 7 and 8 encode the catalytic domain of the FIX protein. " More than 1,380 mutations in the human FIX gene have been identified; unique mutations account for 552 of the 1,380 reported mutations.' The mutations include point mutations, short (less than 30 nucleotides) additions andor deletions, double mutations, triple mutations, and somatic mosaics. Many of these mutations occur at CG hotspots, where the C or the G is deaminated to form a T or A, re~pectively.~.'
A canine model of hemophilia B that closely mimics the disease in human beings has been described and the canine FIX cDNA has been sequenced.8s9 The coding region has 86% homology, at the amino acid level, with human FIX. There is only one previously described mutation in the canine FIX gene.' A missense mutation was found at nucleotide 1477 (G + A), that resulted in a glycine to a glutamic acid substitution in the catalytic domain. The purpose of this study was to characterize the genetic basis for FIX deficiency in a separate model of the disease found in Lhasa Apso dogs.
MATERIALS AND METHODS
Experimental animals. Normal, heterozygous, and FIX-deficient dogs were healthy and disease free at the time of study. Experimental animals were housed in a facility accredited by the American Association for Laboratory Animal Care. The experimental protocols were approved by the institutional Animal Care and Concerns Committee.
Two milliliters of blood was colActivated clotting time (ACT). don in the nucleotide sequence encoding the activation peptide. The mutation was verified by sequencing genomic DNA from an FIX-deficient dog. A genetic test for the detection of heterozygous animals was established using heteroduplex analysis. Although hemophilia B has been described in many dog breeds, this is only the second mutation to be sequenced. The Lhasa Apso dog model should be valuable for evaluating novel strategies for treating hemophilia B such as gene therapy. 0 1996 by The American Sociefy of Hematology.
lected into a prewarmed (37°C) ACT tube containing 6 to 10 mg siliceous earth (Becton Dickinson VACUTAINER Systems, Rutherford, NJ); the sample was mixed by inverting the tube 5 times and was incubated at 37°C. After a 1 minute incubation, the tube was removed from the heating block at 15 second intervals to observe the appearance of the first visible clot. The normal range for dogs is 64 to 95 seconds." Plasma samples were obtained from blood collected with 0.109 mom trisodium citrate at a 9: 1 ratio. One hundred microliters of actin cephaloplastin (Baxter, Miami, FL) was prewarmed to 37°C to which 100 p L of the test plasma was added and the mixture was incubated at 37°C for an additional 3 minutes. One hundred microliters of prewarmed 0.02 m o m calcium chloride (Baxter) was added and the time to initial clot formation determined with a fibrometer (Becton Dickinson and Co, Cockeysville, MD). The normal range for dogs is 14 to 20 seconds."
Ninety-six well enzyme-linked immunosorbent assay (ELISA) plates were coated with 100 &/well of a mouse antihuman factor IX monoclonal antibody (Boehringer Mannheim, Indianapolis, IN) diluted 1:lOO in 0.1 m o m sodium bicarbonate (pH 9.4) for 2 hours at room temperature, rinsed 5 times with 0.05% Surfact-Amps Tween 20 in phosphate-buffered saline (PBS), and then blocked for 1 hour at room temperature using Super Block (Pierce, Rockford, IL). One hundred microliters of plasma was then applied to each well and the plates were incubated at 4°C overnight, rinsed with 0.05% Surfact-Amps Tween 20 in PBS, incubated with 100 pL of a 1:50 dilution of a rabbit antihuman FIX for 2 hours at room temperature, rinsed, and incubated with 100 pL of a peroxidase-conjugated goat anti-rabbit IgG (H + L) (Accurate, Westbury, NY) diluted 1:2,000 in Super Blocker for 2 hours at room temperature. The plates were developed with 100 pL of 1 mg/mL 2,2'-Azinobis(3-ethylbenzothiazoline-6-sulfonic acid)diammonium salt for 30 minutes or until sufficient color developed, then the reaction was stopped using SO p L of 1% sodium dodecyl sulfate (SDS). The assay was read at 405 nm on an ELISA plate reader (SLT Lab Instruments, Tecan, Research Traingle Park, NC). The assay sensitivity was 0.4% of normal canine plasma FIX levels.
Mononuclear cells were isolated from 10 mL of whole blood using 30 mL of a red blood cell lysis buffer (155 mmolL NH.,CI, 10 mmol/L NH,HC03, 0.1 mmolL EDTA)." The mononuclear cells were collected by centrifugation and then resuspended in 3 mL of DNA extraction buffer (10 mmoln Tris, 0.1 molL EDTA, O S % SDS, pH 8.0) containing 400 pg of proteinase K and incubated ovemight at 60°C. The digest was then subjected to two rounds of pheno1:chloroform:isoamyl (2524: 1) (GIBCO-BRL, Gaithersburg, MD) extraction and one ch1oroform:isoamyl extraction (24: I). Genomic DNA was then precipitated with a one-fifth volume of IO molL NH40AC and two and one-half volumes EtOH. DNA was digested with BamHI and EcoRI, separated by agarose gel electrophoresis, transferred to a nylon membrane, and subjected to Southern blot analysis. The probe, a purified 501 bp polymerase chain reaction (PCR) amplicon (3x2-AIX5) from canine FIX cDNA, was labeled with "P-dCTP using the random hexamer method with a Random Prime-it kit (Strategene, La Jolla, CA) according to the manufacturer's instructions. The blot was washed to a final stringency of 0.1 x SSC and 0.1% SDS at 65°C.
Total hepatic RNA was isolated using standard procedure^.'^^'^ Briefly, 3 g of liver was homogenized with 10 mL of 4 molL guanidinium isothiocyanate (GTC) and 7.8 yL of 8-mercaptoethanol, N-lauryl sarconisate and sodium citrate were then added to a final concentration of 0.5% and 25 mmolL, respectively. The mixture was extracted once with phenolkhlorofodisoamyl alcohol (25:24: I ), precipitated with isopropanol/sodium acetate and resuspended in diethylpyrocarbonate (DEPC) treated water and RNAsin (Promega, Madison, WI). Total hepatic RNA was separated by formaldehyde gel electrophoresis and subjected to Northern analysis using the same probe as used for Southern blot analysis. The blot was stripped by boiling in 0.1 X SSPE, 1 % SDS for 30 minutes and rehybridized with a mouse P-actin probe to estimate RNA loading. Synthesis of single-stranded cDNA from total hepatic RNA of a FIX-deficient dog was performed using the Superscript RT kit (GIBCO-BRL), 6 yg total hepatic RNA, and 0.1 pmol/L of sequence specific antisense primer AIXl ("CCCCAGAAAGAGAAAAACCAG"). The RNA and primer were combined, heated to 90"C, and then cooled to 70°C for primer annealing. SuperScript reverse transcriptase, dNTPs, synthesis buffer, and dithiothreitol (DTT) were then added and the reaction tube incubated at 45°C for approximately 2 hours. The cDNA was then amplified by PCR using several sequence specific primer pairs, which were based on the canine factor IX cDNA sequence.x Several primers had additional nucleotides incorporated (lower case letters) to create restriction enzyme sites (underlined nucleotides). The location of each primer in the normal canine FIX cDNA sequence is indicated by superscript numbers. The primer pairs were SIXl , cccggatclWCATCAGCAAAGGTTAGZU'; AIX6, hh2CACCTTGTTATCGGGGCCCAATTT63y; SIX4, 5'6GACGGT-GTATGCAAGGATGACATT53y; AIX4, ccctctayZ3GACCTGCC-AAGGGAATTYU7; SIX2, CCC~~~~~~ACCCGTGCTGAAACTCTT~" ; AIXS, 1274GACTCTCCCCCAmCACATA'25y; SIXS, ''%A-GCCCTTAACGCTGAACAGCTAT1lX7 AIX2, CC~'~'~GGA~CCCCT-TGTCCATTTTCT'62"; GSIX4, 73hGTGGAAGAGTTTCTGTCC-CTCAC7"; GAIX4, y'hCAAGGGAATTGACCTGGT'rTGGC*'4. Northern blot analysis.
Reverse transcription (RT) and DNA amplifcation.
phates, sequence specific primers (each at a concentration of 0.1 ymoVL), and 2.5 U of thermostable Taq DNA polymerase (Promega). Amplification was performed in a F'TC-100 thermal cycler (MJR Research, Inc, Watertown, MA) with an initial denaturing step of 95°C for IO minutes, followed by 40 cycles of annealing at 55°C for 1 minute, extension at 72°C for 2 minutes, and denaturing at 94% for 1 minute.
The FIX cDNA sequence from a hemophilia B dog was determined from overlapping PCR amplicons. The Taq polymerase was removed from PCR reaction mixtures using Strataclean resin (Stratagene) and the samples were then desalted and concentrated using Amicon spin columns (Amicon. Inc, Beverly, MA). The termini of the PCR products were filled in using 5 U of Klenow DNA polymerase (NEB, Beverly, MA) and phosphorylated using 4 U of T4 polynucleotide kinase (NEB). The SIX5-AIX2 and GSIX4-GAIX4 amplicons were then blunt-end ligated into the Sma I digested, dephosporylated pGEM-4Z vector. SIXl -AIX6, SIX4-AIX4, and SIX2-AIX5 PCR amplicons were selfligated to form concatomers, digested with the appropriate restriction enzyme to generate homologous sticky ends, and then ligated into the dephosphorylated pGEM-42 vector, which had been digested with the same restriction enzyme. Competent DH5a cells (GIBCO-BRL) were transformed with the ligation reactions and plated on ampicillidX-Gal coated LB agar plates. Positive clones were identified by PCR using sequence specific primers and sequenced with the Sequenase version 2.0 T7 DNA polymerase sequencing kit (US Biochemical, Cleveland, OH). The sequencing reactions were performed according to manufacturer's instructions. The nucleotide sequences were compared to the previously published normal canine sequence*.'4 and discrepancies between the normal canine factor IX sequence and that obtained from the hemophilic animal were verified by sequencing genomic DNA. At least 2 clones of each amplicon, except for SIX4-AIX4 which contained the mutation, were sequenced on the sense and antisense strands and were identical to the normal canine FIX cDNA sequence. Two clones from the SIX4-AIX4 amplicon and 2 GSIX4-GAIX4 genomic clones were sequenced in both directions and were identical to the normal canine sequence except for the mutation.
Genomic DNA from normal, heterozygous, and FIX-deficient dogs was amplified by PCR using sequence specific primers GSIX4 and GAIX4. The PCR reactions were separated by agarose gel electrophoresis using a 4% Metaphor XR gel (FMC Bioproducts, Rockland, ME) at 129V for 3 3 hours. In some cases, the PCR amplicons were treated with SI nuclease (GIBCO-BRL) before agarose gel electrophoresis.
Subcloning and DNA sequencing.
Heteroduplex analysis.
RESULTS
Clotting parameters. The coagulation tests in the two affected male dogs were consistent with FIX deficiency. The APTT clotting times were 47.5 and 60 seconds (normal range 14 to 20 seconds) and the ACT times were 5' 3 0 and 3' 15" (normal range 64 to 95 seconds) for dogs A and B, respectively." Both dogs had FIX levels of < 1 % in a FIX specific APTT, whereas the other intrinsic clotting factors were normal or increased. The hemophilia B dogs also had < I % of the normal canine plasma FIX antigen level.
Southern and Northern analysis. Southern blot and Northern blot analysis were performed to determine the molecular basis for the severe FIX deficiency. The restriction fragment length digestion patterns for the two FIX-deficient dogs and two normal dogs were similar in DNA digested with BarnHI and EcoRI indicating there were no large rearrangements, additions, or deletions in the FIX gene (data For personal use only. on October 31, 2017. by guest www.bloodjournal.org From 5) from hemophilia B (lanes 2 and 5)  and normal animals (lanes 1 and 4) was analyzed by formaldehyde gel electrophoresis. Hybridization was performed using a "P-labeled canine FIX probe. The same blot was stripped and reprobed with "P-labeled p-actin to verify equal loading of RNA. Lane 3, empty.
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not shown). Northern blot analysis of total hepatic RNA from a normal and hemophilic dog showed a single 3 kb band when probed with the canine FIX cDNA (Fig 1) . Although the apparent size of the FIX mRNA was similar in the normal and hemophilic dog, the quantity of FIX mRNA was significantly decreased in the hemophilic dog (Fig 1,  lanes 2 and 5) . even though the blot was loaded equivalently as determined by probing for &actin mRNA (Fig 1) .
Factor IX deficiency in the Chapel Hill hemophilia B dog colony is due to a G -+ A transition at nucleotide 1477." The G -+ A transition results in the creation of a new restriction site for Ddel, which is the basis for a PCR diagnostic test. Amplification of canine genomic DNA, using specific sense and antisense primers, results in a 133 bp product in both normal and mutant DNAs. However, Ddel digestion of mutant DNA generates bands of 54 bp and 79 bp, whereas normal DNA is resistant to Ddel digestion. The 133 bp amplicon from both FIX-deficient Lhasa Apso dogs was resistant to Ddel digestion (data not shown) indicating that the FIX deficiency in these animals is caused by a different mutation than the previously published G -+ A transition.
The entire coding region of the FIX-deficient cDNA from a FIX-deficient Lhasa Apso dog (Dog A) was sequenced by the dideoxynucleotide chain termination method with PCR amplified hepatocyte cDNA. The sequence was identical to that previously reported, except for a 5 bp deletion at nucleotides 772-776 and a C --f T transition at nucleotide 777 resulting in a transcriptional frameshift and a termination codon at amino acid 146 of the mutant sequence (Fig 2) . This mutation was verified by sequencing genomic DNA from a second FIX-deficient dog (Dog B).
Heteroduplex analysis. Genomic DNA from normal, heterozygous, and affected dogs was amplified using FIX primers GSIX4 and GAIX4, which flank the 5 bp deletion. The expected amplicon sizes are 181 and 176 bp in normal and FIX-deficient dogs, respectively. The normal and FIX deficient dogs had single bands at 18 1 bp and 176 bp, respectively, but surprisingly, a distinct band appeared at approximately 225 bp in heterozygous dogs and with a mixture of DNA from normal and FIX-deficient dogs (Fig 3) . The upper band in DNA from heterozygous dogs and mixed DNA from normal and affected dogs disappeared after SI nuclease digestion (Fig 3, lanes 6 and 8) .
DdeI mutation analysis.
FIX-mutation in Lhasa Apso dogs. samples that were not digested with S1 nuclease, whereas plus (+I signs indicate PCR products that were subjected to S1 nuclease digestion before electrophoresis.
ture stop codon and a complete absence of functional FIX. The decreased amount of FIX mRNA on the Northern blot suggested either a promotedenhancer regulatory defect resulting in decreased transcriptional initiation or mRNA instability caused by premature termination. Because the mutation causes the expresdon of a premature termination codon at amino acid 146, it is likely that the decreased mRNA levels are caused by transcript instability. This conclusion is supported by the fact that mRNA stability for triosephosphate isomerase, &hexosaminidase A, &globin, histones, and pyruvate kinase were decreased when the coding region was shortened or lengthened in association with either a frameshift or nonsense mutation.'"'" Mutations in the human FIX gene have been extensively characterized and provide insight into the patterns and distribution of mutations occurring within a gene. Of the 1,380 patient entries in the sixth edition of the hemophilia B data base, there were 86 deletions, 21 additions, and 6 entries involving both deletions and additions of <30 nucleoMore than 25% of the independent mutations observed in the factor IX gene are transitions at the dinucleotide CpG." Transitions at the dinucleotide CpG occur approximately 24-fold more frequently than transitions at non-CpG dinucleotide^.^'^^^ Analysis of mutations in the human FIX gene supports the hypothesis that the Lhasa Apso mutation is caused by a 5 bp deletion at position 772-776 with cytosine deamination at position 777. There have been no additions or deletions reported at position 777 in the human gene but there have been 23 cases of C --* T transition occurring at this nucleotide position in the human gene.5 Alternatively, the mutation could result from a 6 bp deletion with an insertion of a single T. The exact mechanism for the dog mutation is not known but a purine rich consensus sequence common tides.'.21 .?2 to deletion hot spots in 5 different human genes, a direct repeat element (CACGCACcc) and an inverted palindrome (CACGcAccCGTG) are adjacent to or involved in the deletion mutation (bold nucleotides). The purine rich and secondary structure elements are implicated as mutational hot spots caused by polymerase a arrest and slipped mispairing loops during DNA replication.*'
The nonsense mutation found in the Lhasa Apso dog model results in the expression of a termination codon at amino acid position 146 and thus a predicted protein of considerably shorter length as compared to 414 amino acids for the wild-type protein. The deletioddearnination mutation in the Lhasa Apso dog occurs immediately preceding the activation peptide with the termination codon being the first codon encoded in the activation peptide. The truncated protein would lack the catalytic domain and should not have enzymatic activity. There are 5 frameshift mutations in the human database just 5' to the Lhasa Apso dog mutation which also result in FIX activity and FIX antigen levels that are <I%.' The canine FIX mutation that was previously reported by Evans et al' has not been identified in the human FIX gene. The missense mutation at nucleotide 1477 (G 4 A) is located in the catalytic domain of the FIX gene. The Chapel Hill mutation is thought to cause steric hindrance, which prevents proper folding of the molecule and structural instability. The mutations in the Chapel Hill and Auburn hemophilia B dogs are different but both result in severe hemophilia B.
The Chapel Hill mutation resulted in the creation of a new restriction enzyme recognition site for Ddel, which was used to develop a genetic test that could distinguish normal, mutant, and heterozygous animals.' The 5 bp deletion in the Lhasa Apso dogs did not result in the appearance of a new restriction enzyme site, so heteroduplex analysis was used to establish a genetic test. Heteroduplex analysis is a rapid and reliable method for detecting single base changes, deletions, and additions.*"'* A 181 bp PCR amplicon (GSIX4-GAIX4) from genomic DNA consistently formed a heteroduplex with DNA from heterozygous animals, thus allowing rapid detection of carrier animals. Mixtures of DNA from normal and mutant animals also generated the novel 225 bp heteroduplex band, confirming that PCR amplification of DNA coding for the normal and mutant alleles results in spontaneous heteroduplex formation. Heteroduplex analysis has also been used to screen for single base changes in exon 6 of the human FIX gene.2y
The Lhasa Apso hemophilia B model should be valuable for investigating novel methods for treating hemophilia B such as gene therapy. Characterization of the molecular basis of hemophilia B in Lhasa Apso dogs showed a complex deletion/transition mutation that results in severe hemophilia B.
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